Abstract: The present invention discloses methods for treating bacterial infections in a subject comprising administering to the subject a sub-growth inhibiting amount of a 5?-methylthioinosine phosphorylase (MTIP) inhibitor, as well as assays for identifying such inhibitors, and compounds and pharmaceutical compositions comprising the inhibitors.
Type:
Grant
Filed:
November 28, 2011
Date of Patent:
March 22, 2016
Assignees:
Albert Einstein College of Medicine, Inc., Victoria Link Limited
Inventors:
Vern L. Schramm, Keith Clinch, Peter Charles Tyler, Gary Brian Evans, Richard Hubert Furneaux
Abstract: A self-cleaning optical system for the transmission or reflection of light to and/or from a process region comprises a liquid bath and a transparent or reflective optical component continuously rotatable about a non-vertical axis so that a lower part of the component continuously rotates through the bath. When the component emerges from the bath, a coating of the liquid remains thereon which forms a substantially uniform film on at least a part of the component through which the light is transmitted or from which the light is reflected.
Type:
Grant
Filed:
May 16, 2013
Date of Patent:
March 22, 2016
Assignee:
University College Dublin, National University of Ireland, Dublin
Inventors:
Fergal O'Reilly, Kenneth Fahy, Paul Sheridan
Abstract: Provided are methods of preparing polymers, such as polyisoprene, polybutadiene, polypiperylene, polycyclohexadiene, poly-?-farnesene, or poly-?-myrcene, using iron complexes. Also provided are novel iron complexes, pre-catalysts, intermediates, and ligands useful in the inventive polymerization system.
Type:
Grant
Filed:
February 8, 2012
Date of Patent:
March 22, 2016
Assignee:
President and Fellows of Harvard College
Inventors:
Tobias Ritter, Jean B. Raynaud, Jessica Yung Wu
Abstract: 2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid amino acid derivatives having antiinflammatory properties are provided. Pharmaceutical compositions and methods for preventing or treating inflammation or a disease or condition mediated by inflammation are described.
Type:
Grant
Filed:
February 11, 2014
Date of Patent:
March 22, 2016
Assignee:
Trustees of Dartmouth College
Inventors:
Michael B. Sporn, Karen T. Liby, Martine Cao, Evans O. Onyango, Liangfeng Fu, Gordon W. Gribble
Abstract: The invention provides a method for forming an immobilized agent gradient within a 3-dimensional porous scaffold. A 3-dimensional scaffold formed from a biocompatible material is provided. The surface of the scaffold and/or the agent is activated so as to allow binding of the agent to the scaffold. The activated scaffold is contacted with a solution containing the agent. Contact with the solution is maintained for a sufficient period of time to allow diffusion of the solution through a portion of the scaffold, thereby forming a desired gradient of the agent through the 3-dimensional scaffold.
Type:
Grant
Filed:
April 19, 2006
Date of Patent:
March 22, 2016
Assignees:
Trustees of Tufts College, Massachusetts Institute of Technology
Inventors:
Charu Vepari, David L. Kaplan, Gordana Vunjak-Novakovic
Abstract: A method for augmenting expression of a heterologous nucleic acid in a eukaryotic cell or increasing the efficiency of gene expression using any gene expression system is carried out by decreasing expression or activity of an endogenous Interferon-induced protein-16 (IFI16).
Type:
Application
Filed:
May 5, 2014
Publication date:
March 17, 2016
Applicant:
President and Fellows of Harvard College
Abstract: Immunogenic compositions containing Escherichia coli 0157:H7 flagella including fusion proteins and methods using the immunogenic compositions are disclosed. Inducing an immune response in an animal to Escherichia coli O157:H7 flagella will result in prevention of colonization by Escherichia coli O157:H7 in the animal or a reduction in the amount of Escherichia coli O157:H7 infecting the animal. The immune composition will prevent or reduce the attachment of Escherichia coli 0157:H7 to cells within the animal.
Type:
Application
Filed:
November 23, 2015
Publication date:
March 17, 2016
Applicants:
The University Court of the University of Edinburg h, Moredun Research Institute, The Scottish Agricultural College
Inventors:
David GALLY, Tom Nathan MCNEILLY, David George Emslie SMITH, Chris LOW, Arvind Kumar MAHAJAN, Stuart W. NAYLOR
Abstract: A method of diagnosing metastatic potential of a breast cancer in an individual with breast cancer is described. The method comprises a step of assaying a breast cancer tumor sample from the patient for expression of A Disintegrin and Metalloproteinase 22, (ADAM22), wherein expression of ADAM22 correlates with increased potential for metastasis compared with a patient who is ADAM22 negative. The invention also describes an agent for use in the treatment of metastatic breast cancer in a patient, in which the agent is selected from leucine-rich, glioma-inactivated protein 1 (LGI1) protein (SEQ ID NO:1) and an LGI1 peptide mimic capable of mimicking the ADAM22 binding activity of LGI1 by binding to the LGI1 binding domain of ADAM22 (SEQ ID NO: 4) and which is capable of inhibiting migration of endocrine resistant breast cancer cells.
Type:
Grant
Filed:
November 5, 2012
Date of Patent:
March 15, 2016
Assignee:
Royal College of Surgeons in Ireland
Inventors:
Leonie Young, Damian McCartan, Christopher Byrne
Abstract: Disclosed is a method of treating cancer, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that inhibits a plurality of mammalian dipeptidyl peptidase (DPP) IV activity and/or structural homologues thereof (DASH) serine proteases. Also disclosed is a method of (a) increasing antitumor immunity, (b) stimulating or enhancing an immune response, (c) treating a condition characterized by abnormal cell proliferation, (d) increasing cytokine and/or chemokine production, or (e) stimulating or enhancing production of T-cells, in a mammal, comprising administering to a mammal in need thereof an effective amount of a compound that inhibits a plurality of mammalian DASH serine proteases. For example, the compound that inhibits a plurality of mammalian DASH serine proteases may be t-butylGly-boroPro.
Abstract: The present invention provides novel analogs and derivatives of halofuginone. The invention also provides pharmaceutical and cosmetic compositions thereof and methods for using halofuginone analogs in treating chronic inflammatory diseases, autoimmune diseases, dry eye syndrome, fibrosis, scar formation, angiogenesis, viral infections, ischemic damage, transplant and implant rejection, neurodegenerative diseases, and cosmetic applications.
Type:
Grant
Filed:
August 11, 2009
Date of Patent:
March 15, 2016
Assignees:
President and Fellows of Harvard College, Children's Medical Center Corporation
Inventors:
Tracy Keller, Ralph Mazitschek, Malcolm Whitman, Jinbo Lee, Mark S. Sundrud, Anjana Rao
Abstract: A separator is disclosed that may be used to separate oil from water in situ in the ocean or other water body. The difference in density between oil and water causes them to separate between two limbs of the apparatus, and to exit from different ports at different heights. The input may contain oil:water in essentially any ratio. The apparatus may be placed within a boat or ship, or it may be mounted on pontoons or other floatation gear and towed behind a boat or ship.
Type:
Grant
Filed:
May 25, 2011
Date of Patent:
March 15, 2016
Assignee:
Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
Abstract: Methods for decreasing proliferation and preventing or treating a neuroendocrine cancer using an N-methyl D-aspartate-associated (NMDA) glutamate receptor antagonists or binding agent, such as an antibody, antibody fragment or peptide aptamer specific for a NMDA glutamate receptor, are disclosed.
Abstract: The invention provides methods for characterizing cellular physiology by incorporating into an electrically excitable cell an optical reporter of, and an optical actuator of, electrical activity. A signal is obtained from the optical reporter in response to a stimulation of the cell. Either or both of the optical reporter and actuator may be based on genetically-encoded rhodopsins incorporated into the cell. The invention provides all optical methods that may be used instead of, or as a complement to, traditional patch clamp technologies and that can provide rapid, accurate, and flexible assays of cellular physiology.
Type:
Application
Filed:
November 16, 2015
Publication date:
March 10, 2016
Applicant:
President and Fellows of Harvard College
Inventors:
Adam E. Cohen, Joel Kralj, Adam D. Douglass, Daniel Hochbaum
Abstract: A method for correcting a spinal deformity is provided. A spinal implant for correcting a spinal deformity includes a multipoint connector that connects to at least one vertebra of a spine at a plurality of locations and a force directing device that applies a force to the vertebra through the multipoint connector. The force directing device may include a rod which extends generally along an axis of the spine and a force directing member which is adjustably coupled to both the rod and the multipoint connector and which applies a corrective force to the at least one vertebra.
Abstract: Antimicrobial compounds are provided that are polymerizable. The compounds include monomers with antimicrobial properties. The compounds have cross-linking properties and are hydrolytically stable. The compounds may be utilized in dental and/or medical applications, including dental composites, dentures, bonding agents, sealants, resins and medical devices.
Type:
Application
Filed:
April 8, 2014
Publication date:
March 10, 2016
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Abstract: Compositions and methods are disclosed that employ Tousled-like kinase to selectively protect normal tissues from the adverse effects of radiation therapy, genotoxic chemotherapy and the like without protecting cancer tissues; or to sensitize cancer cells to such cancer therapies without similarly sensitizing normal tissues; or both protect normal cells and sensitize cancer cells. The compositions and methods may be used as a complementary therapy to selectively reduce adverse effects of the principal therapy (radiation therapy or chemotherapy) in normal tissues, with minimal impact on the antitumor effects of the principal therapy.
Type:
Application
Filed:
September 9, 2015
Publication date:
March 10, 2016
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Abstract: A three-dimensional porous photonic structure, whose internal pore surfaces can be provided with desired surface properties in a spatially selective manner with arbitrary patterns, and methods for making the same are described. When exposed to a fluid (e.g., via immersion or wicking), the fluid can selectively penetrate the regions of the structure with compatible surface properties. Broad applications, for example in security, encryption and document authentication, as well as in areas such as simple microfluidics and diagnostics, are anticipated.
Type:
Grant
Filed:
November 21, 2011
Date of Patent:
March 8, 2016
Assignee:
President and Fellows of Harvard College
Inventors:
Joanna Aizenberg, Ian B. Burgess, Lidiya Mishchenko, Benjamin Hatton, Marko Loncar
Abstract: Subjecting a heterogeneous cell population (one with both stem cells and non-stem cells) to extreme stress selectively eliminated the non-stem cells and resulted in the enrichment of stem cells in the population. The stress can take many forms, including without limitation, cell toxins, high temperature, high salt, and low oxygen (hypoxic) conditions. The number of stem cells remaining after stress were increased, and showed increased expression of traditional stem cell markers. The stem cells were shown to be capable of proliferation and differentiation into multiple types of cells. This method allows purification of stem cells from adult heterogeneous cell populations on a large scale basis without requirement of expensive equipment, and without requiring the presence of cell surface markers. Stem cells produced by the above method can be used for clinical applications, including tissue engineering.
Type:
Grant
Filed:
July 18, 2013
Date of Patent:
March 8, 2016
Assignee:
Board of Supervisors of Louisiana State University And Agricultural and Mechanical College